Navigation Links
Caliper Life Sciences to Present at Leerink Swann's 3rd Annual Life Science Tools Roundtable Conference
Date:7/31/2008

HOPKINTON, Mass., July 31 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that its presentation at the Leerink Swann's Life Science Tools Roundtable Conference in Boston, Massachusetts, will be webcast on Thursday, August 7 at 12:50 p.m. EDT. Kevin Hrusovsky, President and CEO of Caliper, will be providing an update on the company's business. The live webcast can be accessed at http://www.wsw.com/webcast/leerink17/calp/. An archived presentation will be available for 90 days.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Caliper Life Sciences Reports First Quarter 2008 Results
2. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
3. Caliper Life Sciences Ships 500th IVIS Imaging System
4. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
5. iCAD Completes Acquisition of CAD Sciences
6. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
7. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
8. BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative
9. Derma Sciences Launches Two New MEDIHONEY(TM) Formulations
10. Microsoft Announces Winners of the 2008 Pharmaceutical and Life Sciences Innovation Awards
11. Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... ... September 23, 2017 , ... A ... fighting obesity of Robert Kushner, director of Chicago’s Center for Lifestyle Medicine at ... healthier habits, the article notes that the center routinely recommends weight loss surgeries ...
(Date:9/23/2017)... ... September 23, 2017 , ... “You Can't Win Them All”: the ... their business ventures and on the ice changed the lives of young athletes. ... Cosimo Filane was born and educated in Schreiber, a small town in Northern Ontario, ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... On Sunday, ... Walk and 5K honoring Olympian, Florence Joyner, still considered the fastest woman of all ... Flo Jo’s daughter, Mary Joyner, will sing the National Anthem. Mary was ...
(Date:9/22/2017)... Plano, TX (PRWEB) , ... September 22, 2017 , ... ... created to strengthen the communities they serve as part of the nationally recognized ‘Agents ... by working closely with nonprofit organizations and community leaders to seek out those who ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and financial setbacks, a senior finds a new lease on life with assistance ... thousands of people resolve their problem with unsecured debt. The senior is one ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017  Medical professionals are expected to ... treating their patients. Medical simulations offer clinicians ... patients. Simulation provides a safe method for ... procedures, refine techniques and build confidence, without ... technology, such as augmented reality, will now ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
Breaking Medicine Technology: